- Published at
- by rttnews.com
positive
positive
Allergy Therapeutics Projects FY Revenue Down 7%; Sees Revenue Growth In H2
Allergy Therapeutics plc (AGY.L) issued a trading update for the year ended 30 June 2024. Revenue for the year ended 30 June 2024 is expected to be 7% lower at 55.